Scaling Cell And Gene Therapies: Challenges And Solutions
It is not always easy to go from novel research to a working business plan. There are still problems with prices and safety, as...
The Cell & Gene Therapy – From Innovation To Market Growth
In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to...
Advances And Challenges In The Gene Therapy Manufacturing
Cell and gene treatments are now one of the pharmaceutical industry’s fastest-growing segments, with more and more being investigated for a variety of purposes.
The...
With A CAGR of 4.5%, Global Fluid Handling Sees New Highs
The global market for fluid handling systems is expected to grow from USD 72,765.23 million in 2023 to USD 1,08,322.43 million in 2032. The...
Impact of AI On Drug Development And Discovery Process
Since artificial intelligence (AI) has the exciting potential to transform every sector and change established processes, it is now the talk of the town....
Medical Device Contract Manufacturing Surge To $130 Billion
The Medical Device Contract Manufacturing Market is currently seeing robust growth due to the increasing demand for advanced medical devices, the rising prevalence of...
New FDA Blueprint For Consistent Drug Delivery Performance
The FDA has released a preliminary guide to aid developers of drug-device combination products in creating essential drug delivery outputs- EDDOs that ensure consistent...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...